DV
Dividend Vision

ABEO — Abeona Therapeutics Inc

Abeona Therapeutics Inc (ABEO)

Its deepest 1-year drawdown was 42.3%.

ABEO is an equity fund that tracks a single biotech company rather than functioning as a diversified ETF. With no reported dividend distribution rate, yield profile, or expense ratio data available, it does not operate as a traditional dividend-focused vehicle. This holding appeals primarily to investors seeking direct exposure to a specific healthcare/therapeutics company rather than those pursuing income generation or broad dividend strategies.

ABEO key facts

Asset type
Stock
Asset class
Equity
Inception date
11/05/1984
Last close
$5.99
Market cap
$398,966,016
Average volume
5445200.0
Ex-dividend date
03/31/2000
Beta
1.33
Payout ratio
0.0
P/E ratio
7.3684
Forward P/E
526.3158
EPS
$0.95